Oxcarbazepine BP / EP / IP / USP

Product Name : Oxcarbazepine

CAS : 28721-07-5

Molecular Formula : C15H12N2O2

Molecular Weight : 252.27 g/mol

Pharmaceutical Grade : BP / EP / IP / USP

Therapeutic Category : Anticonvulsant


Global Calcium is one of the leading manufacturers and exporters of Oxcarbazepine CAS no. 28721-07-5, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Oxcarbazepine we hereby state the following facts about the drug:

Oxcarbazepine is an anticonvulsant. It works by decreasing nerve impulses that cause seizures and pain.

Oxcarbazepine is used either alone or with other medicines to treat partial seizures.

Oxcarbazepine is a dibenzazepine carboxamide derivative with an anticonvulsant property. As a prodrug, oxcarbazepine is converted to its active metabolite, 10-monohydroxy. Although the mechanism of action has not been fully elucidated, electrophysiological studies indicate this agent blocks voltage-gated sodium channels, thereby stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing the propagation of synaptic impulses.

Drug Indication

In the United States, oxcarbazepine is indicated as monotherapy in the treatment of partial-onset seizures in patients 4 years of age and older, and as adjunctive therapy in the treatment of partial-onset seizures in patients 2 years of age and older. In Canada, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in patients 6 years of age and older.

Mechanism of action

The exact mechanism through which oxcarbazepine and its active metaoblite, MHD, exert their anti-epileptic effects is unclear, but is thought to primarily involve the blockade of voltage-gated sodium channels. The opening and closing of sodium channels allows for the propagation of action potentials along neurons - in epilepsy, these action potentials can occur in excess of that required for normal function, and the repetitive and pathological firing of these action potentials leads to seizure activity.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market